Company Overview of Gamma Pharmaceuticals Inc.
Gamma Pharmaceuticals, Inc. operates as a marketing and product formulation company. The company focuses on the formulation, marketing, and sale of vitamins and nutriceuticals, over the counter pharmaceutical products, and personal care products in the Greater China and the United States. Its product formulations are based on its proprietary ‘Gel Delivery Technology’ and are marketed and sold as wellness products. The company offers a suite of gel product forms, including gummy gels, liquid gels, crystal gels, and gel strips. Its products include hand sanitizer lotion, supplement multivitamins, supplement calcium, supplement vitamin C, and adjunctive supplement immune boosters and energy boo...
855 Village Center Drive
St. Paul, MN 55127-3016
Founded in 1993
Key Executives for Gamma Pharmaceuticals Inc.
Chairman of The Board, Chief Executive Officer, Secretary and Chairman of Compensation Committee
President, Chief Financial Officer, Principal Accounting Officer, Treasurer, Director and Chairman of Audit Committee
Compensation as of Fiscal Year 2015.
Gamma Pharmaceuticals Inc. Key Developments
SEC Revokes Registration Of Registered Securities Of Gamma Pharmaceuticals
Oct 1 13
The registration of the registered securities of Gamma Pharmaceuticals, Inc. has been revoked. The Company had repeatedly failed to file required annual and quarterly reports with the Securities and Exchange Commission (SEC). Thus, the Company violated a crucial provision of the federal securities laws that requires public corporations to publicly disclose current, accurate financial information so that investors may make informed decisions. The revocations were ordered in an administrative proceeding before an administrative law judge.
SEC Orders Hearing On Registration Suspension Or Revocation Against Gamma Pharmaceuticals
Sep 12 13
In conjunction with trading suspension, the Securities and Exchange Commission (SEC) also instituted public administrative proceeding to determine whether to revoke or suspend for a period not exceeding twelve months the registration of each class of the securities of Gamma Pharmaceuticals, Inc. for failure to make required periodic filings with the Commission. In this Order, the Division of Enforcement (Division) alleges that the company is delinquent in its required periodic filings with the Commission. In this proceeding, instituted pursuant to Exchange Act Section 12(j), a hearing will be scheduled before an Administrative Law Judge. At the hearing, the judge will hear evidence from the Division and the company to determine whether the allegations of the Division contained in the Order, which the Division alleges constitute failures to comply with Exchange Act Section 13(a) and Rules 13a-1 and 13a-13 there under, are true. The judge in the proceeding will then determine whether the registrations pursuant to Exchange Act Section 12 of each class of the securities of the company should be revoked or suspended for a period not exceeding twelve months. The Commission ordered that the Administrative Law Judge in this proceeding issue an initial decision not later than 120 days from the date of service of the order instituting proceeding.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries